Europe Urinalysis Market (2024-2029)
The Europe Urinalysis Market was valued at $1263.9 Million in 2024 and projected to reach to $1942 Million by 2029, representing a compound annual growth rate of 9.0%. Europe's urinalysis market demonstrates resilient growth momentum, supported by an aging population requiring continuous diagnostic monitoring and a healthcare system prioritizing preventive care.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Europe Urinalysis Market Trends and Insights
- This 9.0% compound annual growth rate reflects Europe's strong healthcare infrastructure, aging population, and increasing prevalence of chronic diseases driving demand for diagnostic testing.
- Europe's advanced laboratory networks and regulatory frameworks support widespread adoption of urinalysis technologies across hospitals, clinics, and diagnostic centers. The European urinalysis market benefits from rising healthcare expenditures and a shift toward preventive medicine across the region.
- In 2024, Europe accounts for a significant share of global urinalysis demand, with growth accelerating through 2029 as automation and point-of-care testing solutions gain traction.
- Europe's emphasis on standardized diagnostic protocols and quality assurance further strengthens market expansion, positioning the region as a key driver of innovation in urinalysis testing methodologies..
Key Market Statistics
- CAGR (2024-2029) 9.0% CAGR
- Market Size, 2024 ~USD 1263.9 Million
- Forecast, 2029 ~USD 1942 Million
- Geography Europe
Europe Urinalysis Market Overview
Market Valuation & Growth :
Europe's urinalysis market is valued at $1,263.9 million in 2024, with a projected expansion to $1,942.0 million by 2029, representing a steady 9.0% CAGR driven by diagnostic demand and healthcare investment.
Aging Population Impact :
Europe's aging demographic significantly drives urinalysis demand, as elderly populations require increased diagnostic testing for chronic disease management, kidney function monitoring, and preventive healthcare screening.
Advanced Healthcare Infrastructure :
Europe's robust laboratory networks, stringent regulatory frameworks, and high healthcare spending create an ideal environment for urinalysis market expansion and adoption of advanced diagnostic technologies.
Chronic Disease Prevalence :
Rising incidence of diabetes, hypertension, and urinary tract infections across European populations fuels consistent demand for urinalysis testing as a primary diagnostic and monitoring tool.
Europe Urinalysis Market Dynamics
- The region's strong regulatory standards and advanced laboratory infrastructure position it as a mature, stable market with consistent expansion opportunities.
- Key drivers include increasing chronic disease prevalence, rising healthcare expenditure, and growing adoption of automated urinalysis systems in clinical laboratories.
- By 2029, the market is expected to reach $1,942.0 million, reflecting sustained demand across hospital, diagnostic center, and point-of-care settings.
- European healthcare providers' emphasis on early disease detection and patient outcomes will continue supporting market growth throughout the forecast period..
Related Ecosystem
In Vitro Diagnostics
- Polymerase Chain Reaction (PCR)
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Dna Microarrays
- Assay Kits
- Microarrays
- ROCHE HOLDINGS AG
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Abbott Laboratories
- Biomerieux s.a.
Medical Devices
- Polymerase Chain Reaction (PCR)
- Magnetic Resonance Imaging (MRI)
- Disposable Autoinjectors
- Pulse Oximeters
- Blood Pressure Monitors
- Medtronic plc
- Abbott Laboratories
- Stryker Corporation
- Becton, Dickinson and Company
- CONMED Corporation
Key Takeaways
- Europe's urinalysis market is valued at $1,263.9 million in 2024 and will reach $1,942.0 million by 2029, growing at a 9.0% CAGR.
- Europe's aging demographic and rising chronic disease prevalence are primary drivers of increased urinalysis testing demand.
- Advanced laboratory infrastructure and stringent regulatory standards in Europe support adoption of automated and point-of-care urinalysis solutions.
- Europe's shift toward preventive healthcare and early disease detection is accelerating market growth through 2029.
Urinalysis Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2024 |
| Fastest Growing Segment | HOSPITALS & CLINICS (End User) |
| Forecast Period | 2024-2029 |
| Growth Rate | CAGR of 9.6% from 2024 to 2029 |
| Largest Segment | CONSUMABLES (Product) |
| Market Size Base Year (Billions) | ~USD 4.3 (2024) |
| Revenue Forecast (Billions) | ~USD 6.8 (2029) |
| Segments Covered | Product, Type, Test Type, Application, End User |
Europe Urinalysis Market Report Segmentation
5 segment dimensions are covered across the global market.
By Product
- Consumables
- Instruments
By Type
- Automated Urine Analyzers
- Biochemical Urine Analyzers
- Brazil
- Diabetes
- Dipsticks
- Disposables
- Flow Cytometry Analyzers
- Integrated Urine Analyzers
- Kidney Diseases
- Laboratory Tests
- Liver Diseases
- Mexico
- Microscopy Analyzers
- Other Disease Screening Applications
- Poc Tests
- Point-Of-Care Urine Analyzers
- Pregnancy & Fertility Kits
- Reagents
- Rest Of Latam
- Sediment Urine Analyzers
- Semi-Automated Urine Analyzers
- Urinary Tract Infections
By Test Type
- Biochemical Tests
- Pregnancy & Fertility Tests
- Sediment Urinalysis
By Application
- Disease Screening
- Pregnancy & Fertility Testing
By End User
- Diagnostic Laboratories
- Home Care Settings
- Hospitals & Clinics
- Research Laboratories & Institutes
REST OF EUROPE: URINALYSIS MARKET, BY END USER, 2022–2029
| Segment | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| DIAGNOSTIC LABORATORIES | 90.1 | 94.7 | 100.5 | 107.5 | 115.9 | 126.4 | 139.2 | 154.9 | 9 |
| HOME CARE SETTINGS | 65.3 | 68.9 | 73.5 | 79.1 | 85.8 | 94.1 | 104.4 | 117.2 | 9.8 |
| HOSPITALS & CLINICS | 71.9 | 78.3 | 86.2 | 95.7 | 107.2 | 121.5 | 139.3 | 161.4 | 13.4 |
| RESEARCH LABORATORIES & INSTITUTES | 16.7 | 17.4 | 18.3 | 19.4 | 20.8 | 22.5 | 24.7 | 27.4 | 8.4 |
| TOTAL | 244 | 259.2 | 278.5 | 301.8 | 329.7 | 364.6 | 407.6 | 461 | 10.6 |
EUROPE: URINALYSIS MARKET, BY END USER, 2022–2029
| Segment | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| DIAGNOSTIC LABORATORIES | 428.8 | 443.8 | 464.1 | 489.2 | 519.6 | 558.1 | 605.4 | 664 | 7.4 |
| HOME CARE SETTINGS | 288.2 | 299.3 | 314.4 | 333 | 355.6 | 384.3 | 419.7 | 463.8 | 8.1 |
| HOSPITALS & CLINICS | 345.7 | 370.8 | 402.4 | 440.2 | 485.7 | 542.3 | 612.1 | 699 | 11.7 |
| RESEARCH LABORATORIES & INSTITUTES | 78 | 80 | 83 | 86.8 | 91.6 | 97.8 | 105.5 | 115.3 | 6.8 |
| TOTAL | 1140.7 | 1193.9 | 1263.9 | 1349.3 | 1452.5 | 1582.4 | 1742.8 | 1942 | 9 |
Target Audience
- In Vitro Diagnostics Manufacturers : IVD companies need Europe-specific market data to assess market size, growth potential, and competitive positioning for urinalysis products across diverse European healthcare systems.
- Healthcare Investors & PE Firms : Investment professionals require detailed European market forecasts and country-level insights to evaluate acquisition targets, portfolio companies, and capital allocation decisions in diagnostic testing.
- Laboratory Service Providers : Clinical laboratory operators need regional market intelligence to understand demand drivers, pricing trends, and expansion opportunities across European diagnostic centers and hospital networks.
- Medical Device Distributors : Distribution companies require country-specific market data to optimize inventory, identify growth markets, and develop targeted sales strategies for urinalysis equipment and reagents.
- Healthcare Consultants & Analysts : Consulting firms and research analysts need comprehensive European market data to support client advisory work, competitive benchmarking, and strategic planning in healthcare diagnostics.
Countries within Europe - compare and drill down
| Country | 2025 size (native) |
|---|---|
| Germany | USD 453.1 Million |
| UK | USD 354.3 Million |
| France | USD 176.5 Million |
| Italy | USD 145.2 Million |
| Spain | USD 128.3 Million |
| Russia | USD 56.4 Million |
| Rest Of Europe | USD 348.6 Million |
Country market size visualization
Reasons to Buy this Report
- Regional Market Segmentation : Gain detailed insights into Europe's urinalysis market with country-level breakdowns including Germany, UK, France, Italy, and Spain, enabling targeted market entry and expansion strategies.
- Competitive Landscape Analysis : Understand market dynamics specific to Europe's advanced healthcare infrastructure, regulatory environment, and key players operating across the region's diagnostic testing sector.
- Growth Opportunity Identification : Identify high-growth segments within Europe's aging population and chronic disease management trends, with actionable insights for product development and market positioning.
- Forecast Accuracy & Reliability : Access validated 5-year forecasts (2024-2029) with 9% CAGR projections based on Europe's healthcare spending patterns, demographic trends, and diagnostic testing adoption rates.
- Strategic Decision Support : Leverage comprehensive market data to support investment decisions, partnership evaluations, and go-to-market strategies tailored to Europe's diverse healthcare systems and regulatory requirements.
Frequently asked questions
What is the current size of Europe's urinalysis market?
Europe's urinalysis market was valued at $1,263.9 million in 2024 and is projected to grow to $1,942.0 million by 2029.
What is the expected growth rate for Europe's urinalysis market?
Europe's urinalysis market is expected to grow at a compound annual growth rate (CAGR) of 9.0% from 2024 to 2029.
What factors are driving growth in Europe's urinalysis market?
Key drivers include Europe's aging population, rising prevalence of chronic diseases, advanced healthcare infrastructure, and increasing adoption of preventive medicine and automated diagnostic solutions.
How does Europe's urinalysis market compare to global trends?
Europe's 9.0% CAGR is slightly below the global average of 9.6%, reflecting mature healthcare systems with steady, sustainable growth rather than rapid expansion.
Which segments are growing fastest in Europe's urinalysis market?
Automated urinalysis systems and point-of-care testing solutions are experiencing the fastest growth in Europe, driven by laboratory efficiency demands and decentralized testing initiatives.
RESEARCH METHODOLOGY
The objective of this study is to analyze the key market dynamics, including drivers, opportunities, constraints, challenges, and strategies employed by key players. Developments within companies, such as acquisitions, product launches, expansions, agreements, and partnerships, will be tracked to assess the competitive landscape of the urinalysis market. This analysis will evaluate market players across various parameters within the broader categories of business and product strategy.
To estimate the market size, both top-down and bottom-up approaches were used. The market breakdown and data triangulation were used to determine the sizes of segments and subsegments.
The four steps involved in estimating the market size are:
Secondary Research
In the secondary research process, various secondary sources, including annual reports, press releases and investor presentations from companies, white papers, certified publications, articles by recognized authors, gold- and silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva), were consulted to identify and collect information for this study.
Primary Research
In the primary research process, interviews with sources from both the supply and demand sides were conducted to gather qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries, as well as preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations across all segments of this industry’s value chain. In-depth interviews were conducted with key industry participants, subject-matter experts, C-level executives at key market players, and industry consultants to obtain and verify critical qualitative and quantitative information and to assess prospects.
Note 1: Other designations include sales, marketing, and product managers.
Note 2: Companies are classified into tiers based on their total revenue. As of 2025, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = <USD 10 million.
|
COMPANY NAME |
DESIGNATION |
|
Sysmex Corporation |
Sales Manager |
|
Thermo Fisher Scientific, Inc. |
Sales Executive |
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the urinalysis market. These methods were also used extensively to estimate the size of various market subsegments. The research methodology used to estimate the market size includes the following:
- The key players in the industry have been identified through extensive secondary research.
- The revenue generated by leading players operating in the urinalysis market was determined through primary and secondary research.
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
The research methodology used to estimate the market size includes the following:
Data Triangulation
After determining the overall market size using the process described above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed wherever applicable. The data was triangulated by analyzing various factors and trends from both the demand and supply sides.
Market Definition
Urinalysis is a procedure used to assess the appearance, concentration, and content of urine. It detects and helps manage various disorders, such as urinary tract infections, kidney diseases, diabetes, and other metabolic disorders. The primary urinalysis tests include biochemical and sediment analysis. In this report, we have also discussed pregnancy and fertility tests for urine analysis.
Key Stakeholders
- Manufacturers and Distributors of Urinalysis Products
- Hospitals & Clinics
- Diagnostic Laboratories
- Research Laboratories & Institutes
- Research & Development (R&D) Companies
- Government Associations
- Venture Capitalists and Investors
Report Objectives
- To define, segment, and forecast the urinalysis market by product, test type, application, technology, end user, and region
- To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
- To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the market segments with respect to five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
- To profile key players and comprehensively analyze their product portfolios, market positions, and core competencies
- To benchmark players within the market using the proprietary Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business and product excellence
- To study the impact of AI on the market, along with the macroeconomic outlook for each region
Available customizations:
MarketsandMarkets offers the following customizations for this market report.
Country Information
- Additional country-level analysis of the urinalysis market
Company profiles
- Additional five company profiles of players operating in the urinalysis market.
Product Analysis
- Product matrix, which provides a detailed comparison of the product portfolio of each company in the urinalysis market
Get the Full Urinalysis Market Report
Full forecast, segment splits, and company analysis for all Urinalysis Market.
- Mexico Urinalysis Market
- Rest Of Europe Urinalysis Market
- Rest Of Asia Pacific Urinalysis Market
- Rest Of Latin America Urinalysis Market
- Canada Urinalysis Market
- US Urinalysis Market
- Germany Urinalysis Market
- UK Urinalysis Market
- France Urinalysis Market
- Italy Urinalysis Market
- Spain Urinalysis Market
- Russia Urinalysis Market
- China Urinalysis Market
- Japan Urinalysis Market
- India Urinalysis Market
- Australia Urinalysis Market
- South Korea Urinalysis Market
- Brazil Urinalysis Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
